SecurityGSK / GlaxoSmithKline plc
InstitutionFinancial Architects, Inc
Shares11,919
Value $ 481,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Financial Architects, Inc reports 4.81% decrease in ownership of GSK / GlaxoSmithKline plc

August 03, 2018 - Financial Architects, Inc has filed a 13F-HR form disclosing ownership of 11,919 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $481,000 USD as of June 30, 2018. Financial Architects, Inc had filed a previous 13F-HR on April 23, 2018 disclosing 12,521 shares of GlaxoSmithKline plc at a value of $489,000 USD. This represents a change in shares of -4.81 percent and a change in value of -1.64 percent during the quarter.

Other investors with positions similar to Financial Architects, Inc include Ballew Advisors, Inc, Pacad Investment Ltd., Burns J W & Co Inc/ny, Signaturefd, Llc, Independent Advisor Alliance, and Mirador Capital Partners LP.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.71 11,919 -4.81 481 -1.64 -24 16 3.25
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 37.27 12,521 34.68 489 48.18 120 39 11.77
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.07 9,297 -22.08 330 -31.96 -100 -55 -11.28
2017-09-30 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.89 11,931 -0.08 485 -5.83 -0 -30 -5.74
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 1,093 44
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 42.64 11,941 -3.19 515 -0.96 -17 12 2.26
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.33 12,334 4.15 520 14.04 20 44 9.69
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.78 11,843 -5.73 456 -15.71 -29 -56 -10.28
2016-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 43.21 12,563 10.69 541 9.96 52 -3 -0.69
2016-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.97 11,350 24.21 492 32.61 93 28 7.59
2016-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.92 9,138 -15.44 371 -12.50 -67 14 3.21
2015-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.82 10,807 17.92 424 20.45 64 8 2.35
2015-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.02 9,165 20.75 352 11.39 63 -27 -8.55
2015-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 7,590 0.00 316 316 0
2014-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2014-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 49.55 1,620 -15.98 74 -28.16 -15 -14 -13.34
2014-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 1,928 103


CUSIP: 37733W105